The United States' recent decision to cancel a $590 million contract with Moderna for the development of an mRNA-based avian influenza vaccine has sparked concern among public health experts.
La entrada U.S. delays mRNA technology, jeopardizing Avian Influenza control se publicó primero en aviNews.